Company Filing History:
Years Active: 2013-2016
Title: Innovations of Robert Schreiber
Introduction
Robert Schreiber is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of chemical manufacturing, particularly in the area of macrocyclic depsipeptides. With a total of 4 patents to his name, Schreiber's work has advanced the understanding and production of these complex compounds.
Latest Patents
Schreiber's latest patents include innovative methods for the solution phase processes for the manufacture of macrocyclic depsipeptides. The first patent details a method for the chemical manufacture of depsipeptides of a specific formula, focusing on new intermediates and their production. The second patent also addresses processes for the manufacture of macrocyclic depsipeptides, emphasizing the same formula and the related invention embodiments.
Career Highlights
Robert Schreiber is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop new chemical processes that have potential applications in pharmaceuticals and biotechnology.
Collaborations
Throughout his career, Schreiber has collaborated with esteemed colleagues, including Murat Acemoglu and Heribert Hellstern. These collaborations have further enriched his research and contributed to the advancement of his inventions.
Conclusion
Robert Schreiber's innovative work in the field of chemical manufacturing has led to significant advancements in the production of macrocyclic depsipeptides. His contributions continue to impact the pharmaceutical industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.